BIOGEN INC. Income Taxes Paid
BIOGEN INC. (BIIB) reported Income Taxes Paid of $185.40 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2024-02-14
- BIOGEN INC. income taxes paid for fiscal 2023 was $185.40M, a 34.54% increase from fiscal 2022.
- BIOGEN INC. income taxes paid for fiscal 2022 was $137.80M, a 89.55% increase from fiscal 2021.
- BIOGEN INC. income taxes paid for fiscal 2021 was $72.70M, a 17.26% increase from fiscal 2020.
- BIOGEN INC. income taxes paid for fiscal 2020 was $62.00M, a 28.74% decline from fiscal 2019.
| Period end | Income Taxes Paid 12 month |
|---|---|
| 2023-12-31 | $185.40M 10-K · filed 2024-02-14 |
| 2022-12-31 | $137.80M 10-K · filed 2023-02-15 |
| 2021-12-31 | $72.70M 10-K · filed 2022-02-03 |
| 2020-12-31 | $62.00M 10-K · filed 2021-02-03 |
| 2019-12-31 | $87.00M 10-K · filed 2020-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |